Skip to main navigation Skip to search Skip to main content

Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine

  • Benjamin Young
  • , Kathleen E. Squires
  • , Karen Tashima
  • , Keith Henry
  • , Stefan Schneider
  • , Anthony LaMarca
  • , Henry H. Zhao
  • , Lisa L. Ross
  • , Mark S. Shaefer

Research output: Contribution to journal › Article › peer-review

Original languageEnglish (US)
Pages (from-to)125-129
Number of pages5
JournalHIV Clinical Trials
Volume16
Issue number4
DOIs
StatePublished - Aug 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antiretroviral therapy
  • GFR
  • Kidney function
  • Renal impairment

Cite this